Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daruka Mahadevan

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Molecular Cancer Therapeutics|June 16, 2017
Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell LymphomasShariful Islam, Wenqing Qi, Carla Morales, et al.
Cancer Immunology Research|August 7, 2019
PD-1 Inhibition Achieves a Complete Metabolic Response in a Patient with Malignant Peripheral Nerve Sheath TumorLisa E Davis, Lauren A Nicholls, Hani M Babiker, et al.
Journal of Cellular Biochemistry|March 21, 2007
Modulation of ligand binding by alternative splicing of the alphaPS2 integrin subunitThomas A Bunch, Timmy L Kendall, Kishore Shakalya, et al.
International Journal of Molecular Sciences|September 9, 2023
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical ValidationJonathan Dao, Patrick J Conway, Baskaran Subramani, et al.
Cancers|March 20, 2020
A Comparative Analysis of Tumors and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients Annotated by 3 Core Cellular ProcessesKristian Larson, Radhamani Kannaiyan, Ritu Pandey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 12, 2022
Pembrolizumab Achieves a Complete Response in an NF-1 Mutated, PD-L1 Positive Malignant Peripheral Nerve Sheath Tumor: A Case Report and Review of the BenchmarksKristian Larson, Atlantis Russ, Hina Arif-Tiwari, et al.
The FEBS Journal|August 24, 2007
Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesisPetra Mlcochová, Anna Plechanovová, Cyril Barinka, et al.
Cancers|January 8, 2025
A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell LymphomaBaskaran Subramani, Patrick J Conway, Aisha Al-Khinji, et al.
Cancers|February 6, 2021
<i>TP53</i> Mutations as a Driver of Metastasis Signaling in Advanced Cancer PatientsRitu Pandey, Nathan Johnson, Laurence Cooke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumorsGeoffrey I Shapiro, Eunice Kwak, Bruce J Dezube, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Molecular Cancer Therapeutics|June 16, 2017
Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell LymphomasShariful Islam, Wenqing Qi, Carla Morales, et al.
Cancer Immunology Research|August 7, 2019
PD-1 Inhibition Achieves a Complete Metabolic Response in a Patient with Malignant Peripheral Nerve Sheath TumorLisa E Davis, Lauren A Nicholls, Hani M Babiker, et al.
Journal of Cellular Biochemistry|March 21, 2007
Modulation of ligand binding by alternative splicing of the alphaPS2 integrin subunitThomas A Bunch, Timmy L Kendall, Kishore Shakalya, et al.
International Journal of Molecular Sciences|September 9, 2023
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical ValidationJonathan Dao, Patrick J Conway, Baskaran Subramani, et al.
Cancers|March 20, 2020
A Comparative Analysis of Tumors and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients Annotated by 3 Core Cellular ProcessesKristian Larson, Radhamani Kannaiyan, Ritu Pandey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 12, 2022
Pembrolizumab Achieves a Complete Response in an NF-1 Mutated, PD-L1 Positive Malignant Peripheral Nerve Sheath Tumor: A Case Report and Review of the BenchmarksKristian Larson, Atlantis Russ, Hina Arif-Tiwari, et al.
The FEBS Journal|August 24, 2007
Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesisPetra Mlcochová, Anna Plechanovová, Cyril Barinka, et al.
Cancers|January 8, 2025
A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell LymphomaBaskaran Subramani, Patrick J Conway, Aisha Al-Khinji, et al.
Cancers|February 6, 2021
<i>TP53</i> Mutations as a Driver of Metastasis Signaling in Advanced Cancer PatientsRitu Pandey, Nathan Johnson, Laurence Cooke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumorsGeoffrey I Shapiro, Eunice Kwak, Bruce J Dezube, et al.
Pageof 13